Predictors of willingness to get a COVID-19 vaccine in the U.S

Author:

Kelly Bridget J.,Southwell Brian G.,McCormack Lauren A.,Bann Carla M.,MacDonald Pia D. M.,Frasier Alicia M.,Bevc Christine A.,Brewer Noel T.,Squiers Linda B.

Abstract

Abstract Background As COVID-19 vaccine distribution efforts continue, public health workers can strategize about vaccine promotion in an effort to increase willingness among those who may be hesitant. Methods In April 2020, we surveyed a national probability sample of 2279 U.S. adults using an online panel recruited through address-based sampling. Households received a computer and internet access if needed to participate in the panel. Participants were invited via e-mail and answered online survey questions about their willingness to get a novel coronavirus vaccine when one became available. The survey was completed in English and Spanish. We report weighted percentages. Results Most respondents were willing to get the vaccine for themselves (75%) or their children (73%). Notably, Black respondents were less willing than White respondents (47% vs. 79%, p < 0.001), while Hispanic respondents were more willing than White respondents (80% vs. 75%, p < 0.003). Females were less likely than males (72% vs. 79%, p < 0.001). Those without insurance were less willing than the insured (47% vs. 78%, p < 0.001). Willingness to vaccinate was higher for those age 65 and older than for some younger age groups (85% for those 65 and older vs. 75% for those 50–64, p < 0.017; 72% for those 35–49, p < 0.002; 70% for those 25–34, p = NS and 75% for ages 18–24, p = NS), but other groups at increased risk because of underlying medical conditions or morbid obesity were not more willing to get vaccinated than their lower risk counterparts. Conclusions Most Americans were willing to get a COVID-19 vaccine, but several vulnerable populations reported low willingness. Public health efforts should address these gaps as national implementation efforts continue.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Reference19 articles.

1. Gottlieb, S., McClellan, M. (21, February 7). What to Do When There’s a Covid-19 Vaccine Glut. Supply is ramping up, but many Americans are reluctant to get the shot and need to be persuaded. The Wall Street Journal. https://www.wsj.com/articles/what-to-do-when-theres-a-covid-19-vaccine-glut-11612732696.

2. Rosenbaum L. NEJM (2021). Escaping Catch-22-Overcoming COVID vaccine hesitancy. New Engl J Med 2021; DOI: https://doi.org/10.1056/NEJMms2101220

3. Lazarus. J.V., Ratzan. S.C., Palayew, A., Gostin L.O., Larson, H.J., Rabin, K., Kimball, S. & El-Mohandes, A. (2020). A global survey of potential acceptance of a COVID-19 vaccine. Nat Med; Epub ahead of print: 1–4.

4. Rhodes A, Hoq M, Measey M-A, Danchin M. Intention to vaccinate against COVID-19 in Australia. Lancet. 2020;S1473:30724–6.

5. Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, et al. Acceptance of a COVID-19 vaccine in southeast Asia: A cross-sectional study in Indonesia. Front Public Health. 2020;8:381.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3